Medicine & Life Sciences
Visceral Leishmaniasis
100%
Trypanosoma cruzi
72%
Chagas Disease
56%
Parasites
54%
Leishmania donovani
50%
Naphthyridines
40%
Proteasome Endopeptidase Complex
29%
Proteasome Inhibitors
27%
Cyclin-Dependent Kinases
26%
Parasitic Diseases
24%
Pharmaceutical Preparations
24%
pyrazolo(3,4-d)pyrimidine
21%
Pharmaceutical Chemistry
20%
Piperazines
20%
Methionine-tRNA Ligase
19%
glycylpeptide N-tetradecanoyltransferase
19%
Leishmania infantum
18%
Pharmacokinetics
18%
Leishmania
18%
Sulfonamides
16%
Cytochromes b
16%
Allosteric Site
16%
African Trypanosomiasis
15%
Piperazine
15%
Nifurtimox
15%
Triazoles
15%
Qi
15%
Metals
14%
benzonidazole
14%
Enzymes
13%
Cross Reactions
13%
Trypanosoma vivax
13%
Chelating Agents
12%
Neglected Diseases
12%
Trypanosoma congolense
12%
Hydroxyl Radical
12%
Divalent Cations
12%
Solubility
12%
Drug Discovery
11%
South America
11%
2,6-dichloro-N-(difluoromethyl)-4-(3-(1-methylpiperidin-4-yl)propyl)-N-(1,3,5-trimethyl-1H-pyrazol-4-yl)benzenesulfonamide
11%
Folic Acid
11%
Therapeutics
10%
Trypanosoma brucei brucei
10%
Proteomics
10%
Communicable Diseases
9%
Binding Sites
8%
Lead
8%
Molecular Biology
8%
Electron Transport Complex III
8%
Chemical Compounds
Nifurtimox
36%
Benznidazole
36%
Parasitic
34%
Proteasome Inhibitor
33%
Metabolic
32%
Drug
17%
Solubility
17%
Naphthyridine
16%
Pyridazinone
16%
Divalent Metal Cation
16%
Buchwald-Hartwig Cross Coupling Reaction
15%
Chemistry
13%
Pipeline
13%
Pharmacokinetics
12%
High Throughput Screening
12%
Piperazine
12%
Cross-Coupling Reaction
11%
Protecting Group
11%
Curing
10%
Pyrimidine
10%
Logd
9%
Pharmacological Metabolism
8%
Genotoxicity
6%